SILENCE THERAPEUTICS PLC

Active London

Research and experimental development on biotechnology

88 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

SILENCE THERAPEUTICS PLC

Research and experimental development on biotechnology

Founded 18 Nov 1994 Active London, United Kingdom 88 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

SR PHARMA PLC 21 Jun 1999 — 26 Apr 2007
STANFORD ROOK HOLDINGS PLC 18 Nov 1994 — 21 Jun 1999
Accounts Due 30 Jun 2026 1 month remaining
Confirmation Submitted 19 Aug 2025 Next due 19 Aug 2026 2 months remaining
Net assets £62M £72M 2025 year on year
Total assets £131M £71M 2025 year on year
Total Liabilities £69M £526K 2025 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

27 Eastcastle Street London W1W 8DH

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SILENCE THERAPEUTICS PLC (02992058), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 18 Nov 1994. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type group
Next accounts 31 Dec 2025
Due by 30 Jun 2026 1 month remaining

Balance Sheet & P&L (2013–2025)

Cash in Bank

£85.11M

Decreased by £62.22M (-42%)

Net Assets

£62.30M

Decreased by £71.72M (-54%)

Total Liabilities

£69.14M

Increased by £526.00k (+1%)

Turnover

£559.00k

Decreased by £42.70M (-99%)

Employees

88

Decreased by 28 (-24%)

Debt Ratio

53%

Increased by 19 (+56%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 8

Investors (15)

Investor NameInvestor SinceParticipating Rounds
Investor 12Mar 2020IPO, Strategic Investment
Investor 9Feb 2021IPO
Investor 13Feb 2021IPO

Share Capital

Share Capital

Share allotments and capital structure

217 Allotments 491,375,038 Shares £3313415203.04m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 May 202510,998£549.9£0.05
29 Nov 20249,999£11k£1.12
29 Nov 20249,999£11k£1.09
29 Nov 20246,777£338.85£0.05
11 Jul 20242,325£9k£4

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (4)

Richard Griffiths Floor 1 Liberation Station Esplanade St Helier Jersey Je2 3as
54.4%
35,477,583
Robert Keith 20 Charles Street London W1j 5dt
18.8%
12,291,528

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Richard Ian Griffiths

British

Active
Notified 4 Aug 2025
Residence Jersey
DOB September 1966
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Richard Ian Griffiths

Ceased 30 Nov 2021

Ceased

Group Structure

Group Structure

SILENCE THERAPEUTICS PLC Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Jan 2026OfficersAppointment of Ms Rhonda Hellums as director on 18 Dec 2025
8 Jan 2026OfficersAppointment of Mr James Lawrence Ede-Golightly as director on 14 Dec 2025
6 Jan 2026OfficersTermination of Craig Tooman as director on 14 Dec 2025
20 Aug 2025Persons With Significant ControlRichard Ian Griffiths notified as a person with significant control
20 Aug 2025Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
9 Jan 2026 Officers

Appointment of Ms Rhonda Hellums as director on 18 Dec 2025

8 Jan 2026 Officers

Appointment of Mr James Lawrence Ede-Golightly as director on 14 Dec 2025

6 Jan 2026 Officers

Termination of Craig Tooman as director on 14 Dec 2025

20 Aug 2025 Persons With Significant Control

Richard Ian Griffiths notified as a person with significant control

20 Aug 2025 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

Recent Activity

Latest Activity

Appointment of Ms Rhonda Hellums as director on 18 Dec 2025

4 months ago on 9 Jan 2026

Appointment of Mr James Lawrence Ede-Golightly as director on 14 Dec 2025

4 months ago on 8 Jan 2026

Termination of Craig Tooman as director on 14 Dec 2025

4 months ago on 6 Jan 2026

Richard Ian Griffiths notified as a person with significant control

9 months ago on 20 Aug 2025

Withdrawal Of A Person With Significant Control Statement

9 months ago on 20 Aug 2025